What smart money is saying about Carasent
1 fund in our archive has pitched Carasent — most recently Kavaljer Quality Focus in May 2026.
Carasent ASA, founded in 1997 and headquartered in Oslo, Norway, delivers cloud-hosted electronic medical record (EMR) and innovative digital healthcare solutions to the healthcare sector across the Nordic region. Its offerings include Webdoc, a comprehensive cloud-native EMR system, and Vårdrummet, an interactive digital platform. Vårdrummet enables healthcare providers to engage with patients through various digital channels such as video consultations and secure chat. The company further provides specialized products including Ad Voca, Ad Opus, and Ad Curis. Previously known as Apptix ASA, the organization officially rebranded to Carasent ASA in May 2019.
Get an email when a fund writes about it
Position history
Every position in Carasent on record in the archive was reported in Q2 2026, across 1 fund letter, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 0 | 1 |
Fund activity · 1 position
- HoldsKavaljer Quality FocusMay 2026
“Carasent represents 4.2% of Kavaljer Quality Focus.”
Read the letterCarasent
Fund coverage · 1 thesis
- Kavaljer Quality FocusMay 2026
Carasent is an electronic medical records platform that is strengthening its moat through a mission-critical acquisition and higher pricing power.
Read the full thesis
Read every full thesis on Carasent
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→